Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Biotech Receives FDA Approval of Second-Generation Medical Device

The product's improvements and the company's commercialization approach were summarized in a Ladenburg Thalmann report. In a June 11 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that the U.S. Food and Drug Administration approved Mot...
Streetwise Reports | June 13, 2019 |

Analyst: Acquisition by Colorado-Based Specialty Pharma 'Could Bolster Revenue 400%'

The benefits and terms of the agreement are outlined in a Ladenburg Thalmann report. In a Sept. 18 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Aytu BioScience Inc. (AYTU:NASDAQ) signed a definitive agreement to acquire Innovus Pharmaceutic...
Streetwise Reports | September 25, 2019 |

Conflict over Kashmir Risks Nuclear Winter, but Gold Goes Down

Many important things happened yesterday. Cohen testified before the Congress, the US-North Korea Summit took place, while tensions between India and Pakistan escalated. Will these developments boost gold? India and Pakistan Engage in Another Conflict over Kashmir India...
Arkadiusz Sieron | February 28, 2019 |

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming

A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. In a May 13 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc.'s (VIVE:NASDAQ) Q1/19 "reads fine." Q1/19 rev...
Streetwise Reports | May 16, 2019 |

Fiscal Year 'Reads Well' for Regenerative Medicine Company

The firm's final quarter and full-year results are reviewed in a Ladenburg Thalmann report. In an Aug. 30 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported Mesoblast Ltd.'s (MESO:NASDAQ; MSB:ASX) financial results for Q4/19 and fiscal year 2019 (FY19)...
Streetwise Reports | September 5, 2019 |

Health Tech Firm Completes Enrollment for Female Sexual Function Trial

A Ladenburg Thalmann report reviewed the study design and purpose. In March 11 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc. (VIVE:NASDAQ) finished enrollment for the VIVEVE II trial of 250 patients across 19 clinical locati...
Streetwise Reports | March 18, 2019 |

What’s with all the weird weather?

In January 2018, something strange happened in the Sahara Desert: it snowed . The Algerian town of Ain Sefra, named the “Gateway to the Sahara”, reportedly received up to an inch, barely enough to get the average North American out of bed early to scra...
Richard (Rick) Mills | July 19, 2019 |

Gold Falls Below $1,300 After Powell’s Testimony: What To Expect From The ECB Meeting?

Powell’s testimony before the Congress is behind us. The ECB meeting is ahead of us. Will Draghi support the gold prices after recent declines? Gold Falls Below $1,300 Gold bulls might be disappointed. The upward trend apparently ended. As one can see...
Arkadiusz Sieron | March 5, 2019 |

OPKO Health Partners with NY State Health Dept. to Create COVID-19 Drive-Thru Testing Facility

OPKO Health shares traded more than 30% higher after the company reported its subsidiary BioReference Laboratories has formed a partnership with the N.Y. State Department of Health to provide COVID-19 testing for the first public drive-through testing facility on the East Co...
Streetwise Reports | March 16, 2020 |

Three safe-haven reasons to own gold

“It’s the tail that wags the dog” is defined by Urban Dictionary as a way of persuading a large group of people. The phrase is usually employed in a situation wherein a cause that expects to elicit a certain effect, is in fact reversed. ...
Richard (Rick) Mills | May 21, 2019 |
1 2
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested